Aveanna Healthcare Holdings Price to Free Cash Flow Ratio 2020-2024 | AVAH
Historical price to free cash flow ratio values for Aveanna Healthcare Holdings (AVAH) since 2020.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Aveanna Healthcare Holdings Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-01-31 | 4.60 | 91.63 | |
| 2024-09-30 | 5.20 | $0.05 | 103.59 |
| 2024-06-30 | 2.76 | $0.06 | 48.85 |
| 2024-03-31 | 2.49 | $-0.01 | 0.00 |
| 2023-12-31 | 2.68 | $0.09 | 30.73 |
| 2023-09-30 | 1.19 | $-0.12 | 0.00 |
| 2023-06-30 | 1.69 | $-0.17 | 0.00 |
| 2023-03-31 | 1.04 | $-0.22 | 0.00 |
| 2022-12-31 | 0.78 | $-0.33 | 0.00 |
| 2022-09-30 | 1.50 | $-0.31 | 0.00 |
| 2022-06-30 | 2.26 | $-0.24 | 0.00 |
| 2022-03-31 | 3.41 | $-0.23 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.945B | $1.895B |
| Aveanna Healthcare Holdings Inc. is a diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna Healthcare Holdings Inc. is based in Atlanta, Georgia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.703B | 0.00 |
| Quest Diagnostics (DGX) | United States | $17.349B | 17.58 |
| DaVita (DVA) | United States | $14.249B | 18.43 |
| Encompass Health (EHC) | United States | $9.629B | 22.70 |
| Chemed (CHE) | United States | $8.394B | 25.80 |
| Elanco Animal Health (ELAN) | United States | $6.076B | 14.46 |
| Option Care Health (OPCH) | United States | $5.267B | 24.96 |
| RadNet (RDNT) | United States | $4.972B | 110.11 |
| LifeStance Health (LFST) | United States | $3.092B | 0.00 |
| Amedisys (AMED) | United States | $3.023B | 21.51 |
| Addus HomeCare (ADUS) | United States | $2.290B | 26.87 |
| Astrana Health (ASTH) | United States | $2.076B | 28.39 |
| U.S Physical Therapy (USPH) | United States | $1.337B | 35.14 |
| Pennant (PNTG) | United States | $0.945B | 38.21 |
| Atai Life Sciences (ATAI) | Germany | $0.252B | 0.00 |
| Bioqual (BIOQ) | United States | $0.055B | 0.00 |
| Daxor (DXR) | United States | $0.038B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.004B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |